Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis ...

Bone metastasis is associated with poor survival rates and a markedly reduced quality of life. Osteocytes, the most abundant cells in bone, are essential for maintaining bone structure and ...

A recent study has uncovered the molecular mechanisms behind osteocyte death in melanoma bone metastasis, revealing that ferroptosis—an iron-dependent form of cell death—plays a central role ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal Orthopaedic Hospital has secured a £110,000 grant from Orthopaedic Research UK to ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Metastatic breast cancer affects people in many ways. The symptoms experienced by each person will vary based on the parts of the body that are affected. Some symptoms are a result of the cancer, and ...

Access the Mets beat like never before Join Post Sports+ for exciting subscriber-only features, including real-time texting ...

Lain Blevins was diagnosed with a rare form of bone cancer after experiencing leg pain, which he and his family put down to ...

Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...